Thank you, Mr. Chair.
I thank the witnesses for their testimony. Their presentations were very stimulating.
My first question is addressed to the U15 representative, and concerns research.
Can you give us a brief overview of the history of research over the past 20 to 25 years, in terms of the funding of granting agencies that provide funds for research, and of the evolution that led to the creation of U15? What do you feel would be the impact of increased investment in primary research?